Increased plasma CgA levels associated with nonalcoholic fatty liver disease.

Background/aims: Chromogranin A (CgA), a major soluble protein released by the neuroendocrine system, functions as a prohormone by giving rise to several biologically active peptides. Our study aimed to evaluate the relationship between CgA levels and nonalcoholic fatty liver disease (NAFLD).

Materials And Methods: In total, 111 NAFLD patients and 120 healthy controls were enrolled in the trial.